|
PRESS RELEASES
Contacts: John J. Viscogliosi, CEO, Raymedica, Inc. (952) 885-0500
RAYMEDICA HIRES NEW CHIEF OPERATING OFFICER
Minneapolis, MN: May 2, 2005 - Raymedica Inc., a medical device developer
and manufacturer, announced that Fred Kornahrens joins Raymedica in
the newly created position of Chief Operating Officer.
“Raymedica has currently refocused by continuing to improve on
the existing PDN® technology, the world’s first nucleus replacement
device, while also creating a comprehensive nucleus replacement system”,
said John J. Viscogliosi, Chairmen and CEO of Raymedica. “Fred
is a seasoned leader that brings over sixteen years of solid medical
device experience to Raymedica including start-up ventures, with over
ten of these years consisting of executive management in medical devices.”
Fred most recently served as a member of the Executive Staff at Zimmer
Spine as Vice President, Global Product Development where he played
a vital role in the development, approval and market introduction of
several spine products. Fred generated & managed multimillion-dollar
budgets leading a global organization of over 40 Product Development,
Clinical and Regulatory personnel. Fred also provided key leadership
for the global integration of Zimmer Spine Product Development. Prior
to joining Zimmer Spine, he served as the Vice President, R&D/Clinical
at IntraTherapeutics, Inc., a cardiovascular start-up that was acquired
by Sulzer Medica. Under Fred’s leadership, the company launched
several Class II & Class III products. He was also instrumental
in the sale of ITI during Sulzer Medica’s divestiture of its cardiovascular
business units in 2002.
“I am honored to be part of the new Raymedica”, said Fred
Kornahrens. “I understand and appreciate the expanding market
need for a nucleus replacement device and Raymedica is the true pioneer
of nucleus replacement with over 3400 implants. The new Raymedica team
has a clear vision to change the paradigm of spine surgery worldwide
by delivering superior patient outcomes, resulting in owning the mindshare
of spine surgeons & maximizing shareholder value”
John Viscogliosi continued by saying, “Prior to his accomplished
medical device career, Fred served for seven years in the Air Force
as a B-52 Pilot and Commander. Fred completed his MBA at Renssselaer
Polytechnic Institute and received his Bachelor of Science, Engineering
from the United States Air Force Academy. He is also a named co-inventor
on several patents.”
About Raymedica, Inc.
Raymedica develops, manufactures and markets medical device systems
designed to treat patients with degenerative disc disease that have
not responded to non-surgical treatment. Raymedica pioneered and is
the scientific, clinical and regulatory leader in the nucleus replacement
segment of the non-fusion spine market. Raymedica devices have been
used in more than 3,400 procedures globally. Raymedica’s products
are currently available worldwide, but are limited to investigational
use only in the United States.
For more information, visit the Company's website at: http://www.raymedica.com.
> Back to Press Releases
|
